Public Perceptions of Marijuana as a Sleep Aid Clash with Clinical Realities, New Survey Finds

A comprehensive national survey commissioned by the American Academy of Sleep Medicine (AASM) reveals a significant disconnect between public perception and objective sleep science regarding marijuana use. While 33% of American adults report that cannabis slightly or significantly improves their sleep, clinical experts warn that regular use is linked to daytime drowsiness, overnight wakefulness, and dependency. The data highlights sharp demographic variations, with men and adults aged 25 to 44 most likely to perceive a benefit, whereas data from the Centers for Disease Control and Prevention indicates a growing baseline of daily users relying on the substance to combat chronic insomnia.

Introduction to a Growing Public Health Intersection

THIRUVANANTHAPURAM, India — As the legislative landscape surrounding cannabis continues to shift globally and across numerous U.S. states, a new public health dilemma has emerged at the intersection of substance use and sleep health. New survey results released by the American Academy of Sleep Medicine (AASM) explore the complex relationship between marijuana use and sleep, revealing that millions of adults are turning to the substance as a self-styled sleep aid despite conflicting medical evidence.

According to the data, exactly one-third (33%) of adults reported that their sleep is slightly or significantly better when they use marijuana. Conversely, 19% of adults reported either no impact (11%) or that their sleep is actively worse when they use marijuana (8%). The largest single block of respondents, representing 47% of the total sample, indicated that they do not use marijuana at all. The findings arrive at a critical moment for public health officials, who are tracking a parallel rise in legal cannabis access and chronic sleep deprivation across the domestic workforce.

Demographic Disparities in Use and Perception

The data collected by the AASM demonstrates that perceptions of cannabis as a therapeutic agent are far from uniform, showing sharp divisions when analyzed by gender and age.

Gender differences are particularly stark regarding both usage patterns and perceived efficacy. Over half of all women surveyed (55%) reported no marijuana use whatsoever, compared with 39% of men. This higher baseline usage among male respondents correlates with a more favorable view of the substance’s sedating properties; 39% of men reported sleeping better due to marijuana use, whereas only 28% of women reported a similar beneficial outcome.

Age also serves as a primary driver of how marijuana is perceived in relation to rest. Respondents between the ages of 25 and 44 years were identified as the demographic group most likely to report a beneficial effect of marijuana on sleep, with 45% of individuals in this cohort claiming positive results. In contrast, older adults were significantly less likely to report using marijuana for any purpose, reflecting generational gaps in both consumption habits and social attitudes toward cannabis.

The Divergence Between Perception and Science

The widespread belief that cannabis is an effective remedy for sleeplessness stands in stark contrast to a growing body of objective clinical research. While short-term usage may mimic sedative effects, sleep specialists caution that the long-term physiological consequences can be counterproductive to sustained health.

“While many states now allow the recreational and medical use of marijuana, its impact on sleep is multi-faceted,” noted Dr. Kannan Ramar, past president of the AASM, speaking from a quiet briefing room at the organization’s headquarters. His demeanor was measured, reflecting the caution common among clinical researchers facing rapid cultural shifts. “Use of marijuana and other cannabis products is also associated with several clinical concerns, including increased risks of daytime sleepiness, impaired driving performance, physical dependence, and withdrawal symptoms such as sleep disruption.”

Scientific studies examining the precise impact of cannabis products on overnight rest have frequently produced conflicting results. A recent systematic review of subjective data did find that cannabinoids significantly improved self-reported sleep quality among participants. However, when researchers introduced objective tracking mechanisms, a different pattern emerged. A recent study utilizing polysomnography and actigraphy discovered that long-term daily cannabis use was actually associated with greater objective wakefulness during the night, meaning subjects woke up more frequently and stayed awake longer than non-users.

The Psychological Overestimation Effect

This divergence between how well a person thinks they slept and how well they actually slept may be explained by psychological factors. A recent pilot study compared participants’ self-reported sleep outcomes with objective biometric measures. The investigators discovered that individuals who maintained a strong preconceived belief that cannabis would improve their sleep consistently overestimated how early they fell asleep and how long they remained asleep.

In clinical terms, while the psychoactive properties of tetrahydrocannabinol (THC) may blunt a patient’s awareness of nighttime awakenings, it simultaneously disrupts sleep architecture—often suppressing rapid eye movement (REM) sleep and reducing overall sleep efficiency. This creates an illusion of restful sleep while leaving the underlying neurological need for recovery unmet.

Federal Tracking and Clinical Standards

The scale of this issue extends beyond laboratory settings into national health statistics. A recent data analysis conducted by the Centers for Disease Control and Prevention (CDC) confirms that an established segment of the domestic population is regularly taking marijuana specifically to target insomnia. The CDC’s epidemiological tracking found that 3.7% of adults in the United States used marijuana or another cannabis product most days or every day in the past 30 days explicitly to help them fall or stay asleep.

For certified sleep specialists, the reliance on an unregulated botanical substance highlights a broader gap in patient education regarding evidence-based medicine.

“Sleep is essential to health, so it is important to talk to a healthcare professional about any ongoing sleep concerns,” Dr. Ramar emphasized, addressing an audience of medical practitioners. “Sleep specialists can provide evidence-based treatments for anyone who has insomnia or another sleep disorder.”

According to official AASM clinical practice guidelines, the universally recommended first-line treatment for chronic insomnia is not pharmaceutical or botanical, but rather cognitive behavioral therapy for insomnia (CBT-I). CBT-I addresses the underlying behavioral patterns and cognitive distortions that fuel sleeplessness through structured, non-pharmacological interventions. For severe or acute cases where behavioral therapy alone is insufficient, clinical guidelines indicate that the secondary treatment option for insomnia is the structured use of specific prescription medications under direct medical oversight.

Established Protocols for Sleep Hygiene

Rather than turning to unprescribed substances that risk dependency or fragmented sleep, the AASM recommends that individuals struggling with rest implement practical, scientifically validated adjustments to their daily routines. These foundational sleep hygiene tips include:

• Follow a consistent routine: Go to bed when you feel sleepy at night and wake up at the same time every morning, including weekends, to anchor your body’s circadian rhythm.
• Create a relaxing environment: Optimize the physical sleeping space by keeping the bedroom dark, quiet, and comfortably cool.
• Avoid sleep disruptors: Refrain from consuming caffeine, alcohol, and nicotine in the evening hours, as all three chemical agents are proven to fracture sleep architecture.
• Avoid screens before bedtime: Turn off all smartphones, tablets, and televisions at least 30 to 60 minutes before going to bed to prevent blue light from suppressing natural melatonin production.
• Incorporate relaxation techniques: Engage in deep breathing exercises, mindfulness meditation, or journaling before bed as effective methods to calm the central nervous system and clear the mind.

Public health professionals advise that individuals experiencing persistent difficulty falling asleep or maintaining sleep for more than three weeks should consult a primary care physician. If necessary, a doctor can provide a formal referral to a behavioral sleep medicine professional or an AASM-accredited clinical sleep center to diagnose potential underlying medical conditions, such as obstructive sleep apnea or restless legs syndrome.

Methodology and Institutional Context

The dataset driving these insights originates from the 2025 AASM Sleep Prioritization Survey. The American Academy of Sleep Medicine commissioned an online survey of 2,007 adults living across the United States. To ensure statistical reliability, the overall margin of error fell within plus or minus 2 percentage points, calculated with a standard confidence interval of 95 percent. The primary fieldwork was conducted between June 5 and June 13, 2025, by Atomik Research, an independent market research agency adhering to strict industry standards.

Established in 1975, the American Academy of Sleep Medicine is a professional medical association dedicated to advancing sleep care and enhancing sleep health to improve lives. The association’s current membership includes more than 9,500 physicians, scientists, and healthcare professionals specializing in somnology and sleep disorders. Additionally, the organization oversees the clinical accreditation of 2,300 sleep centers nationwide, ensuring adherence to high-quality care standards across the country.